MD2722B2 - Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei - Google Patents
Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozeiInfo
- Publication number
- MD2722B2 MD2722B2 MDA20020265A MD20020265A MD2722B2 MD 2722 B2 MD2722 B2 MD 2722B2 MD A20020265 A MDA20020265 A MD A20020265A MD 20020265 A MD20020265 A MD 20020265A MD 2722 B2 MD2722 B2 MD 2722B2
- Authority
- MD
- Moldova
- Prior art keywords
- vitamin
- pharmaceutical composition
- magnesium
- osteoporosis
- prophylaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Invenţia se referă la medicină, şi anume la o compoziţie farmaceutică ce poate fi utilizată pentru profilaxia sau tratamentul osteoporozei.Esenţa invenţiei constă în aceea că compoziţia farmaceutică conţine carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, unde la o doză de calciu de 150…1500 mg, preferabil de 200… 600 mg, pot reveni 100…1000 U.I., preferabil 400…900 U.I. de vitamina D, sau 20…500 mg, preferabil 150…300 mg de magneziu, în care substanţele active ce conţin calciu şi magneziu sunt triturate fin, astfel, încât cel puţin 80% de particule au dimensiuni sub 75 µm; şi, în plus, conţin adjuvanţi convenţionali şi derivaţi ai amidonului farmaceutic acceptabili, preferabil diamidonfosfat în cantitate de 5…40% mas., preferabil de 15…25% mas.; substanţe de origine vegetală abile să formeze xerogeluri cu apa, preferabil carragheenan, în cantitate de 0,1…1,0% mas., preferabil de 0,2…0,6% mas.Compoziţia menţionată reprezintă un praf instant, care, la adiţia formelor lichide, după o agitare de scurtă durată, formează o suspensie geliformă asemănătoare cu o budincă, tolerată bine de pacienţi.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SK498-2000A SK284948B6 (sk) | 2000-04-06 | 2000-04-06 | Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme |
| PCT/SK2001/000004 WO2001076610A1 (en) | 2000-04-06 | 2001-03-15 | Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD20020265A MD20020265A (ro) | 2003-05-31 |
| MD2722B2 true MD2722B2 (ro) | 2005-03-31 |
Family
ID=20435843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20020265A MD2722B2 (ro) | 2000-04-06 | 2001-03-15 | Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1274447A1 (ro) |
| AU (1) | AU2001239668A1 (ro) |
| BG (1) | BG107227A (ro) |
| CZ (1) | CZ303069B6 (ro) |
| EE (1) | EE200200584A (ro) |
| MD (1) | MD2722B2 (ro) |
| PL (1) | PL357777A1 (ro) |
| RU (1) | RU2002130196A (ro) |
| SK (1) | SK284948B6 (ro) |
| WO (1) | WO2001076610A1 (ro) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067150B2 (en) * | 2002-04-16 | 2006-06-27 | Scepter Holdings, Inc. | Delivery systems for functional ingredients |
| US8383154B2 (en) | 2004-05-11 | 2013-02-26 | Egalet A/S | Swellable dosage form comprising gellan gum |
| UA95093C2 (uk) | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Спосіб одержання кальцієвмісної сполуки |
| ATE538774T1 (de) * | 2009-03-26 | 2012-01-15 | Pulmatrix Inc | Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionen |
| MX354829B (es) | 2009-03-26 | 2018-03-22 | Pulmatrix Operating Co Inc | Formulaciones de polvo seco y metodos para el tratamiento de enfermedades pulmonares. |
| EP2464346A1 (en) | 2010-08-30 | 2012-06-20 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| CN107096014B (zh) | 2010-09-29 | 2022-07-15 | 普马特里克斯营业公司 | 吸入用单价金属阳离子干粉剂 |
| CN104487075A (zh) | 2012-02-29 | 2015-04-01 | 普马特里克斯公司 | 可吸入干粉剂 |
| CN105324106A (zh) | 2013-04-01 | 2016-02-10 | 普马特里克斯营业公司 | 噻托铵干粉 |
| JO3456B1 (ar) | 2015-05-13 | 2020-07-05 | H Lundbeck As | فيروتيوكسيتين بيروجلوتامات |
| RU2726438C2 (ru) * | 2018-11-14 | 2020-07-14 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) | Способ получения сухой высокобелковой молочной смеси для профилактики остеопении у детей и подростков с целиакией |
| CN109453126A (zh) * | 2018-12-07 | 2019-03-12 | 浙江核力欣健药业有限公司 | 一种碳酸钙d3咀嚼片的组合物及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5587399A (en) * | 1992-12-23 | 1996-12-24 | Abbott Laboratories | Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases |
| US5637313A (en) * | 1994-12-16 | 1997-06-10 | Watson Laboratories, Inc. | Chewable dosage forms |
| WO1999047122A1 (en) * | 1998-03-16 | 1999-09-23 | Smtm Group, Llc | Chewable calcium supplement and method for making it |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4650669A (en) * | 1985-07-30 | 1987-03-17 | Miles Laboratories, Inc. | Method to make effervescent calcium tablets and calcium tablets produced thereby |
| CA1297035C (en) * | 1987-12-29 | 1992-03-10 | Warner-Lambert Canada Inc. | Chewable, non-gritty calcium citrate tablet |
| US5296476A (en) * | 1989-09-08 | 1994-03-22 | Henderson Esther G | Skin care compositions |
-
2000
- 2000-04-06 SK SK498-2000A patent/SK284948B6/sk not_active IP Right Cessation
-
2001
- 2001-03-15 WO PCT/SK2001/000004 patent/WO2001076610A1/en not_active Application Discontinuation
- 2001-03-15 RU RU2002130196/15A patent/RU2002130196A/ru unknown
- 2001-03-15 EP EP01914325A patent/EP1274447A1/en not_active Withdrawn
- 2001-03-15 CZ CZ20023292A patent/CZ303069B6/cs not_active IP Right Cessation
- 2001-03-15 AU AU2001239668A patent/AU2001239668A1/en not_active Abandoned
- 2001-03-15 MD MDA20020265A patent/MD2722B2/ro unknown
- 2001-03-15 EE EEP200200584A patent/EE200200584A/xx unknown
- 2001-03-15 PL PL01357777A patent/PL357777A1/xx not_active Application Discontinuation
-
2002
- 2002-10-29 BG BG107227A patent/BG107227A/xx unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5587399A (en) * | 1992-12-23 | 1996-12-24 | Abbott Laboratories | Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases |
| US5637313A (en) * | 1994-12-16 | 1997-06-10 | Watson Laboratories, Inc. | Chewable dosage forms |
| WO1999047122A1 (en) * | 1998-03-16 | 1999-09-23 | Smtm Group, Llc | Chewable calcium supplement and method for making it |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001239668A1 (en) | 2001-10-23 |
| PL357777A1 (en) | 2004-07-26 |
| EP1274447A1 (en) | 2003-01-15 |
| MD20020265A (ro) | 2003-05-31 |
| BG107227A (en) | 2003-05-30 |
| WO2001076610A1 (en) | 2001-10-18 |
| SK4982000A3 (en) | 2001-10-08 |
| RU2002130196A (ru) | 2004-03-27 |
| SK284948B6 (sk) | 2006-03-02 |
| CZ303069B6 (cs) | 2012-03-21 |
| EE200200584A (et) | 2004-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2202601T5 (es) | Mejora del sabor de sustancias activas de medicamentos | |
| MD2722B2 (ro) | Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei | |
| WO2001041770A3 (en) | Nanoparticulate eplerenone compositions | |
| MY118371A (en) | Tetrahydrolipstatin containing compositions | |
| WO2002045684A3 (en) | Rapidly dispersing pharmaceutical composition comprising effervescent agents | |
| US3590117A (en) | Long-lasting troche containing guar gum | |
| IE48879B1 (en) | An analgesic effervescent powder and process for its preparation | |
| US3632778A (en) | Tablets containing l-dopa | |
| ZA200301007B (en) | Process for preparing pharmaceutical compositions for use with soft gelatin formulations. | |
| US5922351A (en) | Lubricants for use in tabletting | |
| HUP0004363A2 (hu) | Miltefosint tartalmazó orális szilárd gyógyszerkészítmények leishmaniasis kezelésére | |
| JP6580414B2 (ja) | 生薬末含有錠剤 | |
| WO2008079343A3 (en) | Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients | |
| JP2001097856A (ja) | 鎮咳剤 | |
| KR20010052819A (ko) | 사이클로포스파미드 제피 정제 | |
| US2967131A (en) | Therapeutic composition | |
| CA1119517A (en) | Oral formulations for human use | |
| JP4899304B2 (ja) | 塩酸アンブロキソール含有内服用固形製剤 | |
| EP0272393A3 (en) | Pharmaceutical combination | |
| NZ315632A (en) | Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water | |
| TW561057B (en) | Orally rapidly disintegrable tablet capabling of reducing the bitterness | |
| UA79567C2 (en) | Orodispersible pharmaceutical composition of antithrombolic compound | |
| US20040005366A1 (en) | Healthy bone formulation | |
| GB2336999A (en) | High-dosage triclosan compositions | |
| KR900701284A (ko) | 미분된 콜레스티폴 하이드로클로라이드 |